Where METRNL reduced palmitate-induced nuclear translocation of immune regulating transcription factor nuclear factor kappa B (NFκB), phosphorylation of NFκB inhibitor IκBα, and palmitate-induced insulin resistance, knockdown of AMPK attenuated these effects of METRNL treatments. The gene discussed is NFKB1; the disease is Insulin resistance.